Inotiv (NOTVQ) Total Debt Growth (3y) (2013 - 2026)
Inotiv (NOTVQ) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 5.73% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 10.14% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -4.73% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 7.07% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 5.11% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -60.49% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -12.66% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -0.64% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.58% |
| 10 | Inotiv | 348,881.46 | -14.83 Mn | 111.99 Mn | 3.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.14% |
| Dec 31, 2025 | -74.59% |
| Sep 30, 2025 | -79.31% |
| Jun 30, 2025 | 3.75% |
| Mar 31, 2025 | 3.68% |
| Dec 31, 2024 | 16.01% |
| Sep 30, 2024 | 29.38% |
| Jun 30, 2024 | 159.69% |
| Mar 31, 2024 | 179.65% |
| Dec 31, 2023 | 133.68% |
| Sep 30, 2023 | 131.61% |
| Jun 30, 2023 | 148.69% |
| Mar 31, 2023 | 154.18% |
| Dec 31, 2022 | 163.63% |
| Sep 30, 2022 | 183.39% |
| Jun 30, 2022 | 189.87% |
| Mar 31, 2022 | 220.61% |
| Dec 31, 2021 | 202.53% |
| Sep 30, 2021 | 167.01% |
| Jun 30, 2021 | 117.47% |